Randomized Trial Of A Short Course Of Erlotinib 150 To 300 Mg Daily Prior To Surgery For Squamous Cell Carcinomas Of The Head And Neck (Scchn) In Current, Former, And Never Smokers: Objective Responses And Clinical Outcomes.
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要